LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
3.05
EUR
-0.01
EUR
-0.24 %
07.07.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.55 USD | 0.05 USD | 1.54 % |
|---|
| Vortag | 3.49 USD | Datum | 06.07.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 99.50% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 71.89% | |
| 21Shares Injective Staking ETP | CH1360612134 | 70.04% | |
| 21Shares Jupiter ETP | CH1480821383 | 49.24% | |
| 21shares Gram Staking ETP | CH1297762812 | 43.97% | |
| 21Shares Pendle ETP | CH1495416997 | 28.75% | |
| 21Shares Ondo ETP | CH1396389921 | 26.89% | |
| 21shares Morpho ETP | CH1506167027 | 24.27% | |
| 21Shares Immutable ETP | CH1360612142 | 4.09% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 2.55% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 161.04% | |
| 21shares Canton Network ETP | CH1503127917 | 70.66% | |
| 21shares Morpho ETP | CH1506167027 | 61.44% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 12.34% | |
| 21Shares Jupiter ETP | CH1480821383 | 7.55% | |
| 21shares Gram Staking ETP | CH1297762812 | -7.01% | |
| 21Shares Injective Staking ETP | CH1360612134 | -11.31% | |
| 21Shares Bittensor ETP | CH1495416971 | -22.36% | |
| 21Shares Pendle ETP | CH1495416997 | -37.30% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -44.72% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -2.42% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -8.89% | |
| 21Shares Binance BNB ETP | CH0496454155 | -15.19% | |
| 21Shares Stellar ETP | CH1109575535 | -20.99% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -29.30% | |
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | -31.94% | |
| 21Shares Dogecoin ETP | CH1431521033 | -57.46% | |
| 21Shares Injective Staking ETP | CH1360612134 | -58.61% | |
| 21Shares Immutable ETP | CH1360612142 | -69.08% | |
| 21Shares Sui Staking ETP | CH1360612159 | -75.34% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 154.37% | |
| 21Shares Stellar ETP | CH1109575535 | 125.00% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 51.70% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 35.74% | |
| 21Shares Aave ETP | CH1135202120 | 12.18% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 911’116.72 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 07.07.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 68.43 | |
| Performance 2 Jahre | 83.29 | |
| Performance 3 Jahre | 25.72 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |